Concepedia

Klaus A. Hamacher

KA

Statistics

Publications

11

Citations

1.1K

H-Index

11

Active since

1995

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Cornell University

New York Hospital Queens

NewYork–Presbyterian Hospital

Presbyterian Hospital

Klaus A. Hamacher is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, nuclear medicine, and radiation dosimetry.

Publications per year

1995–2005

11

Publications

11

Targeted α particle immunotherapy for myeloid leukemia

Joseph G. Jurcic, Steven M. Larson, George Sgouros et al. · Blood · 2002 · 467 citations · Full text

Medicine, Hematology, Oncology +14

Validation of GATE Monte Carlo simulations of the GE Advance/Discovery LS PET scanners

C. Ross Schmidtlein, Assen S. Kirov, Sadek A. Nehmeh et al. · Medical Physics · 2005 · 136 citations · Full text

Engineering, Nuclear Engineering, Nuclear Medicine +17

Pharmacokinetics and biodistribution of 111In- and 177Lu-labeled J591 antibody specific for prostate-specific membrane antigen: prediction of 90Y-J591 radiation dosimetry based on 111In or 177Lu?

Shankar Vallabhajosula, Klaus A. Hamacher, Shota Konishi et al. · PubMed · 2005 · 131 citations

Medicine, Nuclear Medicine, Pharmacokinetics +13

Response of LNCaP spheroids after treatment with an alpha-particle emitter (213Bi)-labeled anti-prostate-specific membrane antigen antibody (J591).

Åse Ballangrud, Wei Yang, D.E. Charlton et al. · PubMed · 2001 · 99 citations

Medicine, Nuclear Medicine, Oncology +17

Prediction of myelotoxicity based on bone marrow radiation-absorbed dose: radioimmunotherapy studies using 90Y- and 177Lu-labeled J591 antibodies specific for prostate-specific membrane antigen.

Shankar Vallabhajosula, Stanley J. Goldsmith, Klaus A. Hamacher et al. · PubMed · 2005 · 93 citations

Medicine, Oncology, Pharmacology +16

1–5 of 11